US20210053900A1 - Aqueous Leaching Method to Produce Microcrystalline Powder - Google Patents

Aqueous Leaching Method to Produce Microcrystalline Powder Download PDF

Info

Publication number
US20210053900A1
US20210053900A1 US17/078,480 US202017078480A US2021053900A1 US 20210053900 A1 US20210053900 A1 US 20210053900A1 US 202017078480 A US202017078480 A US 202017078480A US 2021053900 A1 US2021053900 A1 US 2021053900A1
Authority
US
United States
Prior art keywords
cannabinoid
leaching
acids
salts
cannabis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US17/078,480
Inventor
Robert Henry Wohleb
Thomas Jennings Wohleb
Joseph David Friis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US17/078,480 priority Critical patent/US20210053900A1/en
Publication of US20210053900A1 publication Critical patent/US20210053900A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/42Separation; Purification; Stabilisation; Use of additives
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D11/00Solvent extraction
    • B01D11/02Solvent extraction of solids
    • B01D11/0288Applications, solvents
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D11/00Solvent extraction
    • B01D11/04Solvent extraction of solutions which are liquid
    • B01D11/0492Applications, solvents used
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D9/00Crystallisation
    • B01D9/005Selection of auxiliary, e.g. for control of crystallisation nuclei, of crystal growth, of adherence to walls; Arrangements for introduction thereof
    • B01D9/0054Use of anti-solvent
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/42Separation; Purification; Stabilisation; Use of additives
    • C07C51/43Separation; Purification; Stabilisation; Use of additives by change of the physical state, e.g. crystallisation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78Ring systems having three or more relevant rings
    • C07D311/80Dibenzopyrans; Hydrogenated dibenzopyrans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Definitions

  • the present invention relates to plant material extraction processes and products. More specifically, the present invention is directed to extraction methods, and products, and powders of flowers of the cannabis genus.
  • cannabinoid acids show great potential as non-psychoactive medicinal materials.
  • Cannabinoid acids are produced and stored in trichomes on surfaces of the cannabis plant. Concentrates or extracts of cannabis have found favor in medicinal research. Extraction of cannabinoids from cannabis to produce these concentrates has historically been accomplished by organic solvent extraction where dehydrated cannabis is washed with an organic solvent. Pre-dehydration of the cannabis prior to extraction is required for efficient organic solvent extraction. Dehydration of the cannabis plant material often causes some conversion of the cannabinoid acids to their decarboxylated form.
  • the solvents used have been hydrocarbon based solvents or alcohols.
  • Low boiling solvents are normally used to assist in recovery or elimination of the solvent from the extract by heating to vaporize the solvent from the extract or by vacuum distillation. Heating of the concentrate causes at least some additional “activation” or decarboxylation of the acids.
  • the naturally occurring non-psychoactive delta 9-THC-acid can be converted to the psychoactive delta 9-THC by heating. All of these solvents are flammable which may cause safety issues. None of these solvent systems produce a high purity product as the extraction lacks specificity.
  • Hydrocarbons will extract most hydrophobic compounds including high molecular weight lignin, lignans, gums, lignocellulosic material, and the like along with the cannabinoids. Ethanol is more polar than hydrocarbons and therefore also extracts some of the water soluble materials. Concentrates from the organic solvent systems require extensive cleanup in order to produce high purity cannabinoid acids.
  • One such hydrocarbon extraction device utilizes butane as a solvent where the pressurized liquid butane is passed through the plant material in order to effect extraction of the cannabinoids. Residual solvent evaporated from the concentrate under heat/vacuum and is typically released into the atmosphere. Attempts are often made to recycle butane but this is not 100% efficient and hydrocarbons are released to the atmosphere.
  • the concentrate is known as BHO for butane hash oil.
  • U.S. Pat. No. 9,327,210 discloses butane extraction devices and methods of butane extraction.
  • U.S. Pat. No. 9,044,390 discloses a method for forming cannabis concentrates utilizing supercritical fluids with solvent pressure between 750 psi and 25,000 psi and at temperatures between ⁇ 15° C. and 200° C.
  • the equipment used for supercritical fluid extraction is expensive and must be operated by highly trained technicians. Plant material dehydration is required as with hydrocarbon extraction.
  • Concentrates from the foregoing extraction technologies as well as others have strong taste and odor which they impart to edibles. Further these concentrates are in a solid or viscous form and are difficult to mix with food products. Additionally it is difficult to accurately dose edibles or drinks using these concentrates.
  • the solvents and techniques used tend to not discriminate against most pesticides, fungicides or herbicides and instead tend to concentrate these compounds in the final extract or concentrate. It is often found that concentrates will not pass threshold levels when made from plant material that previously passed threshold levels.
  • the present invention discloses methods to extract cannabinoids from flower of the cannabis genus using alkaline water to produce a microcrystalline cannabinoid powder.
  • the invention may use trimmings from freshly harvested flower of cannabis genus or previously dehydrated cannabis plant material.
  • FIG. 1 Typical Cannabinoid acids found in cannabis
  • FIG. 2 Forming soluble salts of cannabinoid acids
  • FIG. 3 Typical LogS vs pH curve for cannabinoid acids
  • FIG. 4 is a process chart for leaching plant material
  • FIG. 5 is a process chart for leaching winterized BHO
  • FIG. 6 list of discriminated pesticides etc.
  • components A, B, and C can consist of (i.e., contain only) components A, B, and C, or can contain not only components A, B, and C but also contain one or more other components.
  • the defined steps can be carried out in any order or simultaneously (except where the context excludes that possibility), and the method can include one or more other steps which are carried out before any of the defined steps, between two of the defined steps, or after all the defined steps (except where the context excludes that possibility).
  • the term “at least” followed by a number is used herein to denote the start of a range including that number (which may be a range having an upper limit or no upper limit, depending on the variable being defined). For example, “at least 1” means 1 or more than 1.
  • the term “at most” followed by a number is used herein to denote the end of a range, including that number (which may be a range having 1 or 0 as its lower limit, or a range having no lower limit, depending upon the variable being defined). For example, “at most 4” means 4 or less than 4, and “at most 40%” means 40% or less than 40%.
  • a range is given as “(a first number) to (a second number)” or “(a first number)-(a second number),” this means a range whose limits include both numbers.
  • “25 to 100” means a range whose lower limit is 25 and upper limit is 100, and includes both 25 and 100.
  • leaching is used where soluble substances are removed from a surface by percolation of an aqueous solution as opposed to solvent extraction.
  • leachate refers to the aqueous solution after it has removed substances from a surface.
  • countercurrent leaching is used to describe leaching where the leaching solution flows in an opposite direction to that of the material being leached.
  • microcrystalline powder is used to describe a crystallized substance or powder that contains small crystals visible only through microscopic examination.
  • LogP is used here to describe the partition coefficient of a molecule between an aqueous and lipophilic phases when in an uncharged state. LogD is similar to logP but is pH dependent, hence one must specify the pH at which the logD was measured. In these disclosures both logP and logD refer to the hydrophobic or lipophilic character of a molecule.
  • Non water soluble acidic cannabinoids may be synthesized primarily within glandular trichomes on the surface of the cannabis plant.
  • the typical cannabinoid acids may be considered to be non-psychotropic to have potential pharmaceutical properties.
  • FIG. 1 is a list with chemical structures of common cannabinoid acids found on the plant surface.
  • Compound 101 THCA ⁇ 9 -tetrahydrocannabinolic acid
  • Compound 102 CBDA CBDA
  • FIG. 1 also shows two other cannabinoid acids commonly found on the surface of the cannabis plant.
  • Compound 103 is CBGA (Cannabigerolic acid) the precursor for THCA and Compound 104 , CBCA (Cannabichromenenic acid).
  • Cannabinoid acids may be classified as weak organic acids. Weak organic acids may react with strong inorganic bases to form salts with increased water solubility.
  • FIG. 2 shows Compound 101 THCA forming the sodium salt sodium tetrahydrocannabinolate (item 201 ) when sodium hydroxide (item 202 ) is used to raise the pH of water. The higher the pH the more salt is formed and the greater the solubility.
  • intrinsic solubility may be defined as the equilibrium solubility of the free acid at a pH where it is fully un-ionized. Where intrinsic solubility is very low it may be convenient to use logS as a measure of solubility where S is the solubility at a temperature of 20-25° C. in mol/L. Calculated intrinsic solubility for THCA may be ⁇ 5.99 at a pH of 1.5.
  • any pH greater than approximately 8.8 may provide adequate solubility of the cannabinoid acids in water for an efficient leaching.
  • Each embodiment may have different extraction requirements so that in practice each embodiment of this invention has an optimal range of pH. For example, freshly harvested plant material may still have intact cuticle which protects the plant interior from leaching of non-cannabinoid acids that would potentially reduce the purity of the final product. This allows for more aggressive leaching of intact plant surfaces.
  • the surface of freshly harvested cannabis flower is the primary source of cannabinoid acids.
  • FIG. 4 is a flowchart depicting the essential elements of the process.
  • the freshly harvested plant material is first washed with water at a pH ⁇ 7 in order to remove water soluble plant materials.
  • the wash water containing the water soluble materials from the plant surface is discarded in step 402 .
  • These water soluble materials are waste that could potentially interfere with product purity.
  • the plant material is leached with alkaline water having a pH range of 11.0 to 12.3 depending on whether the extraction is done in a batch or more efficient countercurrent fashion. When possible a lower pH is preferred as higher pH may solubilize unwanted compounds such as lignins.
  • Sodium hydroxide is typically used for the pH adjustment as it is a strong base and easily forms salts of cannabinoid acids. It is important at step 403 that all of the surface containing trichomes come in contact with the leaching solution. This typically requires agitation. The amount of agitation required is dependent upon the plant maturity and type. Immature flower of cannabis has fairly closed bud requiring more agitation while more mature flower is more open and requires less. The actual required contact time of the alkaline water with the plant surface may be relatively short, typically 20 to 30 seconds. In step 404 , the leached plant material, is now largely depleted of cannabinoid acids, and is discarded.
  • the leachate from step 403 now contains the soluble salts of the cannabinoid acids.
  • the leachate is then filtered to remove extraneous non soluble plant material in step 405 . Filtration down to at least 1 micron insures adequate leachate clarity.
  • the clarified leachate from step 405 may be used as a source for further separation into its individual components by chromatography and the like.
  • the leached cannabinoids may be precipitated by acidifying ( FIG. 2 , item 202 ) the leachate converting the cannabinoid salts back to their non- or low solubility form as cannabinoid acids.
  • acidifying FIG. 2 , item 202
  • the leachate converting the cannabinoid salts back to their non- or low solubility form as cannabinoid acids.
  • the precipitate is collected by filtration, for example with a Buchner funnel, in step 407 and air dried with low humidity into a white or off-white microcrystalline powder.
  • the color of the powder can be affected by the ratio of cannabinoid acids leached from the plant surface.
  • the preferred embodiment may be done batch-wise with aqueous solutions held in vessels such as buckets or barrels.
  • Leaching solution may be placed in multiple barrels so that the cannabis flower may be leached multiple times by going from bucket to bucket or processed in a countercurrent fashion with a screw type conveyor.
  • the starting material may be frozen or previously frozen but not dehydrated plant material. Processing also follows the general guidelines and flow as depicted above in FIG. 4 .
  • the starting material may be previously dehydrated cannabis flower or trim.
  • the process follows the same flow chart as in FIG. 4 except that step 401 is preferred rather than optional.
  • step 401 may serve an additional function by rehydrating the dry material.
  • Rehydrated plant material may function in a similar manner to fresh plant material.
  • Non-rehydrated plant material may present more than the cuticle protected surface of the plant material to the leaching solution allowing solubilizing of non-cannabinoid acids and requires further purification steps.
  • the starting material is a cannabis extract or concentrate such as BHO (butane hash oil), CO2 oil or “distillates”, which is leached with alkaline water from which microcrystalline cannabinoid powder is produced.
  • BHO butane hash oil
  • CO2 oil or “distillates” which is leached with alkaline water from which microcrystalline cannabinoid powder is produced.
  • the process of solubilizing cannabinoid acids by alkaline leaching may be applied in a similar fashion to purify hydrophobic mixtures or oils previously extracted from the cannabis genus.
  • the solubilized salts may then be used for downstream operations or precipitated into a microcrystalline powder.
  • FIG. 5 depicts the elements of this process in a flow chart. As it applies to BHO (Butane Hash Oil) the BHO must first be winterized by any procedure known in the art.
  • the winterized BHO is first dissolved, 501 , in 190-proof ethanol at a rate of approximately 1,000 grams of BHO to each gallon of ethanol.
  • the alcohol/BHO solution is rapidly dispersed, 502 , into an alkaline solution containing 1% sodium chloride forming an emulsion.
  • the emulsion formed is agitated for about 20 minutes, 503 , during which time the cannabinoid acids are solubilized by leaching from the lipophilic emulsified droplets.
  • step 504 the agitation is turned off and the leached particles are allowed to settle.
  • step 505 the leachate is clarified by filtration, centrifugation or other methods known in the art. We typically filter down to 0.5
  • step 506 the leachate is rapidly acidified to a pH of usually less than 3 causing conversion of the cannabinoid salts back to the insoluble acid state causing precipitation in a microcrystalline form.
  • the precipitate is collected by usual ways known in the art including filtration or centrifugation then dried, step 507 , to form powder.
  • the characteristics of the leaching process may be used to discriminate against concentrating most pesticides, fungicides, herbicides, off flavors and the like. Compounds that have a high logD and a negative logS will not be appreciably leached by the alkaline leaching solution and will therefore not contaminate the final microcrystalline powdered cannabinoids.
  • FIG. 6 is a list of commonly tested for mycotoxins, pesticides and fungicides which will not be leached by the alkaline solution. Column 601 gives the names in the list. Column 602 gives the logD at pH 13 and Column 603 gives the logS of each compound. As can be seen in FIG. 6 these compounds all have a positive logD and negative logS.
  • leaching of cannabinoid acids from plant surfaces may be done in a countercurrent fashion either as batches or continuous flow.
  • the starting material is a cannabis extract or concentrate such as BHO (butane hash oil), CO2 oil or “distillates”, which is leached with alkaline water from which microcrystalline cannabinoid powder is produced.
  • BHO butane hash oil
  • CO2 oil or “distillates” which is leached with alkaline water from which microcrystalline cannabinoid powder is produced.
  • the starting material is any material that contains contaminants such as pesticides or off flavors which is leached with alkaline water such that the microcrystalline cannabinoid powder produced is free of off flavors or pesticides.
  • an alkaline extract containing salts of cannabinoid acids is used as starting material for purification of individual cannabinoids.
  • Total mass of cured (dehydrated) bud designated 30.4 Kg for oil production.

Abstract

Non-water soluble cannabinoid acids are isolated from trichomes and flower of cannabis genus by leaching with alkaline water. The leaching with alkaline water converts the cannabinoid acids to water soluble salts. The resulting solution of cannabinoid salts may be used as a source of acidic cannabinoids for pharmaceutical applications or the cannabinoid acid salts may be converted back to their acid form and precipitated into a high purity microcrystalline powder by acidification of the aqueous solution. Compounds that are not water soluble and do not form salts in alkaline water such as many pesticides, fungicides and off flavors will not be concentrated.

Description

    TECHNICAL FIELD
  • The present invention relates to plant material extraction processes and products. More specifically, the present invention is directed to extraction methods, and products, and powders of flowers of the cannabis genus.
  • BACKGROUND
  • Concentrated or purified cannabinoid acids show great potential as non-psychoactive medicinal materials. Cannabinoid acids are produced and stored in trichomes on surfaces of the cannabis plant. Concentrates or extracts of cannabis have found favor in medicinal research. Extraction of cannabinoids from cannabis to produce these concentrates has historically been accomplished by organic solvent extraction where dehydrated cannabis is washed with an organic solvent. Pre-dehydration of the cannabis prior to extraction is required for efficient organic solvent extraction. Dehydration of the cannabis plant material often causes some conversion of the cannabinoid acids to their decarboxylated form.
  • Typically the solvents used have been hydrocarbon based solvents or alcohols. Low boiling solvents are normally used to assist in recovery or elimination of the solvent from the extract by heating to vaporize the solvent from the extract or by vacuum distillation. Heating of the concentrate causes at least some additional “activation” or decarboxylation of the acids. For example the naturally occurring non-psychoactive delta 9-THC-acid can be converted to the psychoactive delta 9-THC by heating. All of these solvents are flammable which may cause safety issues. None of these solvent systems produce a high purity product as the extraction lacks specificity. Hydrocarbons will extract most hydrophobic compounds including high molecular weight lignin, lignans, gums, lignocellulosic material, and the like along with the cannabinoids. Ethanol is more polar than hydrocarbons and therefore also extracts some of the water soluble materials. Concentrates from the organic solvent systems require extensive cleanup in order to produce high purity cannabinoid acids.
  • One such hydrocarbon extraction device utilizes butane as a solvent where the pressurized liquid butane is passed through the plant material in order to effect extraction of the cannabinoids. Residual solvent evaporated from the concentrate under heat/vacuum and is typically released into the atmosphere. Attempts are often made to recycle butane but this is not 100% efficient and hydrocarbons are released to the atmosphere. The concentrate is known as BHO for butane hash oil. U.S. Pat. No. 9,327,210 discloses butane extraction devices and methods of butane extraction.
  • U.S. Pat. No. 9,044,390 discloses a method for forming cannabis concentrates utilizing supercritical fluids with solvent pressure between 750 psi and 25,000 psi and at temperatures between −15° C. and 200° C. The equipment used for supercritical fluid extraction is expensive and must be operated by highly trained technicians. Plant material dehydration is required as with hydrocarbon extraction.
  • Concentrates from the foregoing extraction technologies as well as others have strong taste and odor which they impart to edibles. Further these concentrates are in a solid or viscous form and are difficult to mix with food products. Additionally it is difficult to accurately dose edibles or drinks using these concentrates.
  • Additionally, the solvents and techniques used tend to not discriminate against most pesticides, fungicides or herbicides and instead tend to concentrate these compounds in the final extract or concentrate. It is often found that concentrates will not pass threshold levels when made from plant material that previously passed threshold levels.
  • The use of these concentrates to infuse into other products such as smoking materials to increase cannabinoid content is also difficult due to the oily nature and high viscosity.
  • It would be desirable to have a process for extracting acidic cannabinoids directly from green plant surfaces of cannabis genus without having to first dehydrate the plant material. Furthermore, it would be desirable to be able to use water as the leaching agent for cannabinoids eliminating the use of expensive organic solvents which are potentially polluting. Additionally it would advantageous to have a process that rejects pesticides, fungicides and herbicides. Still further, it would be desirable to have a process for extracting cannabinoids that did not require equipment that is typically expensive and uses high temperature and/or pressure to accomplish the extraction of cannabinoids. It would further be desirable to be able to produce a high purity microcrystalline cannabinoid powder from this aqueous leachate. Still further, it would be desirable to be able to leach acidic cannabinoids from existing solvent extracts. It would further be desirable to have a microcrystalline cannabinoid powder that is easy to disperse into edible products. It would additionally be desirable to have a cannabinoid powder that is essentially odorless and tasteless. Therefore, there currently exists a need in the industry for a simple and inexpensive process that produces a tasteless and odorless cannabinoid powder using an aqueous extraction solvent that can be applied directly to plant surfaces or extracts.
  • SUMMARY OF THE INVENTION
  • The present invention discloses methods to extract cannabinoids from flower of the cannabis genus using alkaline water to produce a microcrystalline cannabinoid powder. Alternatively, the invention may use trimmings from freshly harvested flower of cannabis genus or previously dehydrated cannabis plant material.
  • BRIEF DESCRIPTION OF DRAWINGS
  • The present invention will become more fully understood from the detailed description and accompanying drawings, which are not to scale.
  • FIG. 1 Typical Cannabinoid acids found in cannabis;
  • FIG. 2 Forming soluble salts of cannabinoid acids;
  • FIG. 3 Typical LogS vs pH curve for cannabinoid acids;
  • FIG. 4 is a process chart for leaching plant material;
  • FIG. 5 is a process chart for leaching winterized BHO;
  • FIG. 6 list of discriminated pesticides etc.
  • DETAILED DESCRIPTION
  • In the Summary above and in this Detailed Description, and the claims below, and in the accompanying drawings, reference is made to particular features of the invention. It is to be understood that the disclosure of the invention in this specification includes all possible combinations of such particular features. For example, where a particular feature is disclosed in the context of a particular aspect or embodiment of the invention, or a particular claim, that feature can also be used—to the extent possible—in combination with and/or in the context of other particular aspects and embodiments of the invention, and in the invention generally
  • The term “comprises” and grammatical equivalents thereof are used herein to mean that other components, ingredients, steps, etc. are optionally present. For example, an article “comprising” (or “which comprises”) components A, B, and C can consist of (i.e., contain only) components A, B, and C, or can contain not only components A, B, and C but also contain one or more other components.
  • Where reference is made herein to a method comprising two or more defined steps, the defined steps can be carried out in any order or simultaneously (except where the context excludes that possibility), and the method can include one or more other steps which are carried out before any of the defined steps, between two of the defined steps, or after all the defined steps (except where the context excludes that possibility).
  • The term “at least” followed by a number is used herein to denote the start of a range including that number (which may be a range having an upper limit or no upper limit, depending on the variable being defined). For example, “at least 1” means 1 or more than 1. The term “at most” followed by a number is used herein to denote the end of a range, including that number (which may be a range having 1 or 0 as its lower limit, or a range having no lower limit, depending upon the variable being defined). For example, “at most 4” means 4 or less than 4, and “at most 40%” means 40% or less than 40%. When, in this specification, a range is given as “(a first number) to (a second number)” or “(a first number)-(a second number),” this means a range whose limits include both numbers. For example, “25 to 100” means a range whose lower limit is 25 and upper limit is 100, and includes both 25 and 100.
  • For the purpose of these disclosures the term leaching is used where soluble substances are removed from a surface by percolation of an aqueous solution as opposed to solvent extraction. The term leachate refers to the aqueous solution after it has removed substances from a surface. The term countercurrent leaching is used to describe leaching where the leaching solution flows in an opposite direction to that of the material being leached. The term microcrystalline powder is used to describe a crystallized substance or powder that contains small crystals visible only through microscopic examination. LogP is used here to describe the partition coefficient of a molecule between an aqueous and lipophilic phases when in an uncharged state. LogD is similar to logP but is pH dependent, hence one must specify the pH at which the logD was measured. In these disclosures both logP and logD refer to the hydrophobic or lipophilic character of a molecule.
  • Disclosed herein are methods for leaching non-water soluble cannabinoid acids directly from plant surfaces and trichomes utilizing water with pH control as a leaching agent, in a batch or continuous countercurrent manner. Other insoluble organic acids could be leached from other vegetation surfaces and trichomes however this method may be ideally suited to cannabinoid acids. Further disclosed are methods for utilizing water with pH control to extract acidic cannabinoids from other materials including concentrates from existing extraction technologies.
  • Still further disclosed is a method for forming a cannabinoid microcrystalline powder from the alkaline aqueous leachate again utilizing pH control, the microcrystalline powder being essentially odorless and tasteless.
  • Additionally disclosed is a method for excluding off flavors, pesticides, fungicides, herbicides and the like from the final product or microcrystalline cannabinoid powder.
  • Non water soluble acidic cannabinoids may be synthesized primarily within glandular trichomes on the surface of the cannabis plant. The typical cannabinoid acids may be considered to be non-psychotropic to have potential pharmaceutical properties. FIG. 1 is a list with chemical structures of common cannabinoid acids found on the plant surface. Compound 101 THCA (Δ9-tetrahydrocannabinolic acid) and Compound 102 CBDA (Cannabidiolic acid) are common acids found on the surface of the cannabis plant. FIG. 1 also shows two other cannabinoid acids commonly found on the surface of the cannabis plant. Compound 103 is CBGA (Cannabigerolic acid) the precursor for THCA and Compound 104, CBCA (Cannabichromenenic acid). Cannabinoid acids may be classified as weak organic acids. Weak organic acids may react with strong inorganic bases to form salts with increased water solubility. FIG. 2 shows Compound 101 THCA forming the sodium salt sodium tetrahydrocannabinolate (item 201) when sodium hydroxide (item 202) is used to raise the pH of water. The higher the pH the more salt is formed and the greater the solubility.
  • For the case of cannabinoid acids, intrinsic solubility may be defined as the equilibrium solubility of the free acid at a pH where it is fully un-ionized. Where intrinsic solubility is very low it may be convenient to use logS as a measure of solubility where S is the solubility at a temperature of 20-25° C. in mol/L. Calculated intrinsic solubility for THCA may be −5.99 at a pH of 1.5. FIG. 3 is a plot of calculated solubility for Compound 101, THCA, as logS, 302, plotted against solution pH, 303. It can be seen that item 301 at a pH=8.8 that logS is equal to 0 or equal to 1 mol/L. Increasing pH above 8.8 causes additional increases in logS and solubility. Each change in pH ±0.1 may change the solubility of the cannabinoid acid 10 fold. THCA is used here as an example. There may be slight differences in logS plots for the other cannabinoid acids.
  • In theory any pH greater than approximately 8.8 may provide adequate solubility of the cannabinoid acids in water for an efficient leaching. Each embodiment may have different extraction requirements so that in practice each embodiment of this invention has an optimal range of pH. For example, freshly harvested plant material may still have intact cuticle which protects the plant interior from leaching of non-cannabinoid acids that would potentially reduce the purity of the final product. This allows for more aggressive leaching of intact plant surfaces.
  • In a preferred embodiment, the surface of freshly harvested cannabis flower is the primary source of cannabinoid acids. FIG. 4 is a flowchart depicting the essential elements of the process. In an optional step 401, the freshly harvested plant material is first washed with water at a pH ≤7 in order to remove water soluble plant materials. The wash water containing the water soluble materials from the plant surface is discarded in step 402. These water soluble materials are waste that could potentially interfere with product purity. In step 403, the plant material is leached with alkaline water having a pH range of 11.0 to 12.3 depending on whether the extraction is done in a batch or more efficient countercurrent fashion. When possible a lower pH is preferred as higher pH may solubilize unwanted compounds such as lignins. Sodium hydroxide is typically used for the pH adjustment as it is a strong base and easily forms salts of cannabinoid acids. It is important at step 403 that all of the surface containing trichomes come in contact with the leaching solution. This typically requires agitation. The amount of agitation required is dependent upon the plant maturity and type. Immature flower of cannabis has fairly closed bud requiring more agitation while more mature flower is more open and requires less. The actual required contact time of the alkaline water with the plant surface may be relatively short, typically 20 to 30 seconds. In step 404, the leached plant material, is now largely depleted of cannabinoid acids, and is discarded. The leachate from step 403 now contains the soluble salts of the cannabinoid acids. The leachate is then filtered to remove extraneous non soluble plant material in step 405. Filtration down to at least 1 micron insures adequate leachate clarity. At this point in the process, the clarified leachate from step 405 may be used as a source for further separation into its individual components by chromatography and the like.
  • Alternatively, as indicated in step 406, the leached cannabinoids may be precipitated by acidifying (FIG. 2, item 202) the leachate converting the cannabinoid salts back to their non- or low solubility form as cannabinoid acids. Referring again to rapid precipitation in this manner causes the formation of microcrystals of the collected cannabinoids. The precipitate is collected by filtration, for example with a Buchner funnel, in step 407 and air dried with low humidity into a white or off-white microcrystalline powder. The color of the powder can be affected by the ratio of cannabinoid acids leached from the plant surface.
  • The preferred embodiment may be done batch-wise with aqueous solutions held in vessels such as buckets or barrels. Leaching solution may be placed in multiple barrels so that the cannabis flower may be leached multiple times by going from bucket to bucket or processed in a countercurrent fashion with a screw type conveyor.
  • In an additional embodiment the starting material may be frozen or previously frozen but not dehydrated plant material. Processing also follows the general guidelines and flow as depicted above in FIG. 4.
  • In an alternate embodiment the starting material may be previously dehydrated cannabis flower or trim. The process follows the same flow chart as in FIG. 4 except that step 401 is preferred rather than optional. With dry material, step 401 may serve an additional function by rehydrating the dry material. Rehydrated plant material may function in a similar manner to fresh plant material. Non-rehydrated plant material may present more than the cuticle protected surface of the plant material to the leaching solution allowing solubilizing of non-cannabinoid acids and requires further purification steps.
  • In still another embodiment, the starting material is a cannabis extract or concentrate such as BHO (butane hash oil), CO2 oil or “distillates”, which is leached with alkaline water from which microcrystalline cannabinoid powder is produced. In this method, the process of solubilizing cannabinoid acids by alkaline leaching may be applied in a similar fashion to purify hydrophobic mixtures or oils previously extracted from the cannabis genus. The solubilized salts may then be used for downstream operations or precipitated into a microcrystalline powder. FIG. 5 depicts the elements of this process in a flow chart. As it applies to BHO (Butane Hash Oil) the BHO must first be winterized by any procedure known in the art. The winterized BHO is first dissolved, 501, in 190-proof ethanol at a rate of approximately 1,000 grams of BHO to each gallon of ethanol. The alcohol/BHO solution is rapidly dispersed, 502, into an alkaline solution containing 1% sodium chloride forming an emulsion. We typically use a pH of 11.5 to 11.6 and a ratio of alcohol/BHO solution to alkaline aqueous solution of 1:80. These conditions are not limited in scope but solely example of suitable conditions. The emulsion formed is agitated for about 20 minutes, 503, during which time the cannabinoid acids are solubilized by leaching from the lipophilic emulsified droplets. In step 504, the agitation is turned off and the leached particles are allowed to settle. In step 505, the leachate is clarified by filtration, centrifugation or other methods known in the art. We typically filter down to 0.5 In step 506, the leachate is rapidly acidified to a pH of usually less than 3 causing conversion of the cannabinoid salts back to the insoluble acid state causing precipitation in a microcrystalline form. The precipitate is collected by usual ways known in the art including filtration or centrifugation then dried, step 507, to form powder.
  • In an additional embodiment, the characteristics of the leaching process may be used to discriminate against concentrating most pesticides, fungicides, herbicides, off flavors and the like. Compounds that have a high logD and a negative logS will not be appreciably leached by the alkaline leaching solution and will therefore not contaminate the final microcrystalline powdered cannabinoids. FIG. 6 is a list of commonly tested for mycotoxins, pesticides and fungicides which will not be leached by the alkaline solution. Column 601 gives the names in the list. Column 602 gives the logD at pH 13 and Column 603 gives the logS of each compound. As can be seen in FIG. 6 these compounds all have a positive logD and negative logS.
  • In an alternative embodiment leaching of cannabinoid acids from plant surfaces may be done in a countercurrent fashion either as batches or continuous flow.
  • In still another embodiment, the starting material is a cannabis extract or concentrate such as BHO (butane hash oil), CO2 oil or “distillates”, which is leached with alkaline water from which microcrystalline cannabinoid powder is produced.
  • Additionally, in another embodiment the starting material is any material that contains contaminants such as pesticides or off flavors which is leached with alkaline water such that the microcrystalline cannabinoid powder produced is free of off flavors or pesticides.
  • In an additional embodiment an alkaline extract containing salts of cannabinoid acids is used as starting material for purification of individual cannabinoids.
  • Certain embodiments of the present invention include the foregoing presented embodiments, but are not limited to them.
  • The following examples utilize a batch process, are purely illustrative and are not meant to be limiting in application or scope of process.
  • Examples Leaching of Cannabinoid Acids from Fresh Plant
  • Total mass of freshly harvested cannabis plant material = 991 Kg
    Volume of aqueous leaching solution containing 0.5% 7,570 L
    NaCl and adjusted to a pH of 12.3 with NaOH =
    Mass of microcrystalline powder obtained = 14.3 Kg
    Percent THCA by HPLC analysis = 91.93%
    Percent CBDA by HPLC analysis =  6.94%
    Total acidic cannabinoids = 98.87%
  • Leaching of Cannabinoid Acids from Dehydrated Bud Material
  • Total mass of cured (dehydrated) bud designated 30.4 Kg
    for oil production. =
    Volume of water rinse at a pH of 6.5 adjusted 625 L
    by the addition of HCl =
    Volume of alkaline leaching solution with 0.5% 1,150 L
    NaCl adjusted to a pH of 11.5 with NaOH =
    Mass of microcrystalline powder obtained = 3,040.8 gr
    Percent THCA by HPLC analysis = 89.23%
    Percent CBDA by HPLC analysis =  6.75%
    Total acidic cannabinoids = 95.98%
  • Leaching of Cannabinoid Acids from BHO
  • A combination of BHO samples containing off flavors etc. were combined into one lot for leaching.
  • Total Mass of BHO to be processed prior 1.26 Kg
    to winterization =
    Volume of alkaline leaching solution with 1.0% 475 L
    NaCl adjusted to pH 11.8 with NaOH =
    Mass of microcrystalline powder obtained = 0.95 Kg
    Percent THCA by HPLC = 86.87% 
    Percent CBDA by HPLC = 3.44%
    Percent CBCA by HPLC = 4.49%
    Percent THCVA by HPLC = 1.22%
    Total acidic cannabinoids = 96.02% 

Claims (9)

The invention claimed is:
1. A method of leaching acidic cannabinoids from lipophilic extracts comprising: preparing alkaline water; dispersing the lipophilic extract into the alkaline water.
2. The method of claim 21 wherein the lipophilic extract is BHO.
3. The method of claim 22 wherein the BHO is winterized.
4. The method of claim 22 wherein the BHO is cryoground before dispersion.
5. The method of claim 21 wherein the lipophilic extract is produced by supercritical CO2 extraction.
6. The method of claim 21 wherein the lipophilic extract is dissolved in a water miscible solvent before dispersing into alkaline water.
7. The method of claim 26 wherein the solvent is ethanol.
8. The method of claim 21 wherein an emulsifier is added to the alkaline water.
9. The method of claim 28 wherein sodium chloride is added as the emulsifier.
US17/078,480 2017-11-29 2020-10-23 Aqueous Leaching Method to Produce Microcrystalline Powder Abandoned US20210053900A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US17/078,480 US20210053900A1 (en) 2017-11-29 2020-10-23 Aqueous Leaching Method to Produce Microcrystalline Powder

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762592293P 2017-11-29 2017-11-29
US16/203,542 US10941102B2 (en) 2017-11-29 2018-11-28 Aqueous leaching method to produce microcrystalline powder
US17/078,480 US20210053900A1 (en) 2017-11-29 2020-10-23 Aqueous Leaching Method to Produce Microcrystalline Powder

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US16/203,542 Division US10941102B2 (en) 2017-11-29 2018-11-28 Aqueous leaching method to produce microcrystalline powder

Publications (1)

Publication Number Publication Date
US20210053900A1 true US20210053900A1 (en) 2021-02-25

Family

ID=68615281

Family Applications (2)

Application Number Title Priority Date Filing Date
US16/203,542 Active US10941102B2 (en) 2017-11-29 2018-11-28 Aqueous leaching method to produce microcrystalline powder
US17/078,480 Abandoned US20210053900A1 (en) 2017-11-29 2020-10-23 Aqueous Leaching Method to Produce Microcrystalline Powder

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US16/203,542 Active US10941102B2 (en) 2017-11-29 2018-11-28 Aqueous leaching method to produce microcrystalline powder

Country Status (1)

Country Link
US (2) US10941102B2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022201043A1 (en) * 2021-03-23 2022-09-29 Pobeltsch-Gle Ad Methods and systems for the extraction of cannabinoids

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10941102B2 (en) * 2017-11-29 2021-03-09 Robert Henry Wohleb Aqueous leaching method to produce microcrystalline powder
EP4017483A4 (en) * 2019-08-22 2023-09-20 Medpharm Iowa LLC Water-based extraction and purification processes for cannabinoid acids
EP4208274A1 (en) 2020-09-04 2023-07-12 Herbolea Biotech S.p.A. Thc-free cannabinoid concentrate, method of obtaining the same and use thereof
WO2022140197A1 (en) * 2020-12-23 2022-06-30 M-For, LLC Extraction and purification of cannabinoids
US20220332694A1 (en) * 2021-04-07 2022-10-20 Aurora Fine Chemicals LLC New water-soluble salts of cannabinoids, preparation and uses thereof

Citations (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020086438A1 (en) * 1998-10-26 2002-07-04 Elsohly Mahmoud A. Method of preparing delta-9-tetrahydrocannabinol
US20050049298A1 (en) * 2002-02-01 2005-03-03 Goodwin Neil John Production of Delta 9 tetrahydrocannabinol
US20050266108A1 (en) * 2002-09-23 2005-12-01 Gw Pharma Limited Methods of purifying cannabinoids from plant material
US20110046213A1 (en) * 2008-05-01 2011-02-24 Resolution Chemicals Limited Production of Delta 9 Tetrahydrocannabinol
US20150038567A1 (en) * 2011-09-29 2015-02-05 The Health Concept Gmbh Cannabinoid Carboxylic Acids, Salts of Cannabinoid Carboxylic Acids, and the Production and Uses of Same
US9044390B1 (en) * 2014-04-17 2015-06-02 Gary J. Speier Pharmaceutical composition and method of manufacturing
US20160106705A1 (en) * 2014-10-21 2016-04-21 United Cannabis Corp. Cannabis extracts and methods of preparing and using same
US9327210B1 (en) * 2014-11-17 2016-05-03 Connoisseur Concentrates, LLC Extraction devices, systems, and methods
US20160214920A1 (en) * 2015-01-22 2016-07-28 Phytoplant Research S.L. Methods of Purifying Cannabinoids, Compositions and Kits Thereof
US20160228385A1 (en) * 2015-02-05 2016-08-11 Colorado Can Llc Purified cbd and cbda, and methods, compositions and products employing cbd or cbda
US20160326130A1 (en) * 2015-05-07 2016-11-10 Axim Biotechnologies, Inc. Process to extract and purify delta-9-tetrahydrocannabinol
WO2016187679A1 (en) * 2015-05-22 2016-12-01 "Pobelch - Gle" Ood Method for preparation of a cannabinoid extract from hemp
US20170008870A1 (en) * 2015-07-06 2017-01-12 Clare J. Dibble Methods for Obtaining Purified Cannabis Extracts and THCA Crystals
WO2017053731A1 (en) * 2015-09-24 2017-03-30 Pasenture, Inc. Cannabinoid compositions and methods of making
US20180162828A1 (en) * 2015-01-22 2018-06-14 Phytoplant Research S.L. Methods of Purifying Cannabinoids, Compositions and Kits Thereof
US20180333446A1 (en) * 2017-05-17 2018-11-22 Folium Biosciences, Llc Cbx extraction-isolation process
US20190010106A1 (en) * 2017-07-07 2019-01-10 Orochem Technologies, Inc. Process for purification and separation of cannabinoids, from dried hemp and cannabis leaves
WO2019043259A1 (en) * 2017-09-04 2019-03-07 Bionorica Ethics Gmbh Recovery of acidic cannabinoids from plant material
WO2019057994A1 (en) * 2017-09-25 2019-03-28 Krotov Vadym New composition and method for the preparation thereof
US20190160393A1 (en) * 2017-11-27 2019-05-30 Beleave Inc. Extraction and purification of cannabinoid compounds
US10941102B2 (en) * 2017-11-29 2021-03-09 Robert Henry Wohleb Aqueous leaching method to produce microcrystalline powder
US20210292295A1 (en) * 2018-07-19 2021-09-23 Al&Am Pharmachem Ltd. Process for purification of tetrahydrocannabinolic- and cannabidiolic acid from plant material extract

Patent Citations (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020086438A1 (en) * 1998-10-26 2002-07-04 Elsohly Mahmoud A. Method of preparing delta-9-tetrahydrocannabinol
US20050049298A1 (en) * 2002-02-01 2005-03-03 Goodwin Neil John Production of Delta 9 tetrahydrocannabinol
US20050266108A1 (en) * 2002-09-23 2005-12-01 Gw Pharma Limited Methods of purifying cannabinoids from plant material
US20110046213A1 (en) * 2008-05-01 2011-02-24 Resolution Chemicals Limited Production of Delta 9 Tetrahydrocannabinol
US20150038567A1 (en) * 2011-09-29 2015-02-05 The Health Concept Gmbh Cannabinoid Carboxylic Acids, Salts of Cannabinoid Carboxylic Acids, and the Production and Uses of Same
US9376367B2 (en) * 2011-09-29 2016-06-28 The Health Concept Gmbh Cannabinoid carboxylic acids, salts of cannabinoid carboxylic acids, and the production and uses of same
US9044390B1 (en) * 2014-04-17 2015-06-02 Gary J. Speier Pharmaceutical composition and method of manufacturing
US20160106705A1 (en) * 2014-10-21 2016-04-21 United Cannabis Corp. Cannabis extracts and methods of preparing and using same
US9327210B1 (en) * 2014-11-17 2016-05-03 Connoisseur Concentrates, LLC Extraction devices, systems, and methods
US20180162828A1 (en) * 2015-01-22 2018-06-14 Phytoplant Research S.L. Methods of Purifying Cannabinoids, Compositions and Kits Thereof
US20160214920A1 (en) * 2015-01-22 2016-07-28 Phytoplant Research S.L. Methods of Purifying Cannabinoids, Compositions and Kits Thereof
US20160228385A1 (en) * 2015-02-05 2016-08-11 Colorado Can Llc Purified cbd and cbda, and methods, compositions and products employing cbd or cbda
US20160326130A1 (en) * 2015-05-07 2016-11-10 Axim Biotechnologies, Inc. Process to extract and purify delta-9-tetrahydrocannabinol
WO2016187679A1 (en) * 2015-05-22 2016-12-01 "Pobelch - Gle" Ood Method for preparation of a cannabinoid extract from hemp
US20170008870A1 (en) * 2015-07-06 2017-01-12 Clare J. Dibble Methods for Obtaining Purified Cannabis Extracts and THCA Crystals
WO2017053731A1 (en) * 2015-09-24 2017-03-30 Pasenture, Inc. Cannabinoid compositions and methods of making
US20180333446A1 (en) * 2017-05-17 2018-11-22 Folium Biosciences, Llc Cbx extraction-isolation process
US20190010106A1 (en) * 2017-07-07 2019-01-10 Orochem Technologies, Inc. Process for purification and separation of cannabinoids, from dried hemp and cannabis leaves
WO2019043259A1 (en) * 2017-09-04 2019-03-07 Bionorica Ethics Gmbh Recovery of acidic cannabinoids from plant material
WO2019057994A1 (en) * 2017-09-25 2019-03-28 Krotov Vadym New composition and method for the preparation thereof
US20190160393A1 (en) * 2017-11-27 2019-05-30 Beleave Inc. Extraction and purification of cannabinoid compounds
US10941102B2 (en) * 2017-11-29 2021-03-09 Robert Henry Wohleb Aqueous leaching method to produce microcrystalline powder
US20210292295A1 (en) * 2018-07-19 2021-09-23 Al&Am Pharmachem Ltd. Process for purification of tetrahydrocannabinolic- and cannabidiolic acid from plant material extract

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
Appendino; Current Medicinal Chemistry, 2011, 18, 1085-1099. (Year: 2011) *
Majors; LCGC North America, 2009, 27(7) 526-533. Downloaded 23 March 2022 from https://www.chromatographyonline.com/view/salting-out-liquid-liquid-extraction-salle (Year: 2009) *
Mechoulam; Chem. Rev. 1976, 76, 75-112. (Year: 1976) *
Rovetto; J. of Supercritical Fluids 2017, 129. 16–27. (Year: 2017) *
Warner; Forensic Chemistry 2017, 3, 52-57. (Year: 2017) *
Wohlfarth; Journal of Chromatography B, 879 (2011) 3059-3064. (Year: 2011) *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022201043A1 (en) * 2021-03-23 2022-09-29 Pobeltsch-Gle Ad Methods and systems for the extraction of cannabinoids

Also Published As

Publication number Publication date
US10941102B2 (en) 2021-03-09
US20190359550A1 (en) 2019-11-28

Similar Documents

Publication Publication Date Title
US20210053900A1 (en) Aqueous Leaching Method to Produce Microcrystalline Powder
US8580116B2 (en) Near-critical fluid extraction process
US9950976B1 (en) Cannabidiol extraction and conversion process
Berna et al. High-pressure solubility data of system ethanol (1)+ catechin (2)+ CO2 (3)
Michielin et al. Radical-scavenging activity of extracts from Cordia verbenacea DC obtained by different methods
JP2019147952A (en) Sesame oil and method for preparing the same
Bras et al. Impact of extraction parameters and concentration by nanofiltration on the recovery of phenolic compounds from Cynara cardunculus var. altilis: Assessment of antioxidant activity
CN107405296A (en) The method that the extract for the matrix for preparing vegetalitas source is extruded by using hydrotropy solution
Drinić et al. Application of conventional and high-pressure extraction techniques for the isolation of bioactive compounds from the aerial part of hemp (Cannabis sativa L.) assortment Helena
Rodrigues et al. Uvaia (Eugenia pyriformis Cambess) residue as a source of antioxidants: An approach to ecofriendly extraction
CN107404926A (en) For in aqueous medium by the use of non-ion amphiphilic compound as extraction adjuvant prepare plant origin matrix extract method
US20080306141A1 (en) Method of Extraction of Catechin Type-A Proanthocyanidins
Clímaco et al. Hibiscus sabdariffa L. leaves as an alternative source of bioactive compounds obtained through high pressure technologies
CN106309509A (en) Inonotus obliquus polyphenol complex and preparation method thereof
US20220211789A1 (en) Extraction of cannabinoids from biomass
US20230123084A1 (en) Method for obtaining a botanical extract
Spigno et al. Recovery of gallic acid with colloidal gas aphrons (CGA)
CA3044911A1 (en) Method to produce a plant extract from plant material
JP2001106636A (en) Production of plant extract
US20160296903A1 (en) Emulsifiers from olive solid waste
KR101835200B1 (en) Cosmetic Composition for Improving Atopic Dermatitis Comprising Extract of Monochoria Korsakowii
PL223434B1 (en) Method for producing plant extracts
Al-Ghanimi Extraction and purification of Gallic acid from Eucalyptus camaldulensis leaves
Tallon et al. Extraction and fractionation of cannabinoids from Cannabis Sativa
RU2650399C1 (en) Method of obtaining extractive substances from giant hyssop anisic

Legal Events

Date Code Title Description
STPP Information on status: patent application and granting procedure in general

Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION

STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION